An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Solid Tumors and Hematologic Malignancy
Interventions: DRUG: INCB054329 Monotherapy
Sponsor: Incyte Corporation